As of 2025-09-16, the EV/EBITDA ratio of Bolt Biotherapeutics Inc (BOLT) is -0.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BOLT's latest enterprise value is 0.61 mil USD. BOLT's TTM EBITDA according to its financial statements is -51.75 mil USD. Dividing these 2 quantities gives us the above BOLT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 14.7x | 13.3x |
| Forward P/E multiples | 14.8x - 29.0x | 19.1x |
| Fair Price | (395.01) - (392.31) | (431.67) |
| Upside | -7524.9% - -7474.3% | -8214.0% |
| Date | EV/EBITDA |
| 2025-09-12 | -0.01 |
| 2025-09-11 | -0.01 |
| 2025-09-10 | -0.01 |
| 2025-09-09 | -0.00 |
| 2025-09-08 | -0.01 |
| 2025-09-05 | -0.01 |
| 2025-09-04 | 0.01 |
| 2025-09-03 | 0.01 |
| 2025-09-02 | 0.00 |
| 2025-08-29 | -0.00 |
| 2025-08-28 | -0.01 |
| 2025-08-27 | -0.01 |
| 2025-08-26 | -0.01 |
| 2025-08-25 | -0.02 |
| 2025-08-22 | -0.01 |
| 2025-08-21 | 0.00 |
| 2025-08-20 | 0.00 |
| 2025-08-19 | 0.01 |
| 2025-08-18 | -0.00 |
| 2025-08-15 | -0.01 |
| 2025-08-14 | -0.02 |
| 2025-08-13 | -0.02 |
| 2025-08-12 | -0.02 |
| 2025-08-11 | -0.02 |
| 2025-08-08 | -0.02 |
| 2025-08-07 | -0.02 |
| 2025-08-06 | -0.02 |
| 2025-08-05 | -0.02 |
| 2025-08-04 | -0.02 |
| 2025-08-01 | -0.02 |
| 2025-07-31 | -0.02 |
| 2025-07-30 | -0.03 |
| 2025-07-29 | -0.04 |
| 2025-07-28 | -0.05 |
| 2025-07-25 | -0.05 |
| 2025-07-24 | -0.06 |
| 2025-07-23 | -0.06 |
| 2025-07-22 | -0.04 |
| 2025-07-21 | -0.03 |
| 2025-07-18 | -0.02 |
| 2025-07-17 | -0.03 |
| 2025-07-16 | -0.03 |
| 2025-07-15 | -0.02 |
| 2025-07-14 | -0.04 |
| 2025-07-11 | -0.04 |
| 2025-07-10 | -0.05 |
| 2025-07-09 | -0.05 |
| 2025-07-08 | -0.04 |
| 2025-07-07 | -0.03 |
| 2025-07-03 | -0.03 |